Skip to main content

Table 1 Baseline characteristics of the sample according to sex

From: Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults

Characteristic

Men (n = 1898)

Women (n = 2095)

P value

Total (n = 3993)

Age (years)

50.80 (16.76)

50.20 (16.05)

0.25

50.49 (16.39)

Weight (kg)

85.32 (15.98)

72.25 (15.74)

<0.0001

78.46 (17.38)

Waist girth (cm)

98.43 (13.03)

87.09 (14.12)

<0.0001

92.47 (14.74)

BMI (kg/m2)

27.89 (4.78)

27.75 (6.04)

0.41

27.82 (5.48)

Overweight (BMI 25.00 – 29.99 kg/m2)1

874 (46.05%)

663 (31.65%)

<0.0001

1537 (38.49%)

Obese (BMI ≥ 30 kg/m2)1

512 (26.98%)

632 (30.17%)

0.03

1144 (28.65%)

Glucose (mmol/L)2

5.1 (4.8-5.6)

4.9 (4.5-5.3)

<0.0001

5.00 (4.6-5.5)

Triglycerides (mmol/L)2

1.3 (0.9-2.0)

1.1 (0.8-1.6)

<0.0001

1.20 (0.9-1.8)

HDL cholesterol (mmol/L)2

1.2 (1.0-1.4)

1.5 (1.2-1.7)

<0.0001

1.30 (1.1-1.6)

Total cholesterol (mmol/L)2

5.1 (4.4-5.8)

5.2 (4.6-6.0)

0.0001

5.2 (4.5-5.9)

Systolic blood pressure (mmHg)

130.90 (17.61)

125.50 (19.15)

<0.0001

128.03 (18.63)

Diastolic blood pressure (mmHg)

82.65 (9.96)

78.79 (10.04)

<0.0001

80.63 (10.19)

Mean arteriole pressure (mmHg)

98.72 (11.20)

94.35 (11.89)

<0.0001

96.43 (11.77)

Metabolic syndrome (ATPIII)1

553 (29.14%)

461 (22.00%)

<0.0001

1014 (25.39%)

Type 2 diabetes1

218 (11.49%)

170 (8.11%)

0.0003

388 (9.72%)

Cardiovascular disease1

199 (10.48%)

120 (5.73%)

<0.0001

319 (7.99%)

Cardiometabolic disease1

363 (19.13%)

251 (11.98%)

<0.0001

614 (15.38%)

  1. Mean (SD) t-test; 1proportions and Chi square; 2median (Q1-Q3) and Wilcoxon Signed Rank.
  2. Abbreviations: BMI Body mass index, ATPIII Adult Treatment Panel III definition.